Pentadecapeptide BPC 157 counteracts L-NAME-induced catalepsy: BPC 157, L-NAME, L-arginine, NO-relation, in the suited rat acute and chronic models resembling positive-like symptoms of schizophrenia
However, long-term trials are necessary to conclude the clinical safety of this peptide
Featured oral research products you can shop right now One of our most requested categories includes oral capsule formats that simplify storage and measurement for controlled lab environments
Canada Direct Peptides offers bacteriostatic water and syringes for sale, go to our designated supplies page for all other research accessories
Novartis delivered FY2024 net sales of USD 51.7 billion, growth of 11% in USD terms (12% at constant currencies), with core operating income up 22% at constant currencies and core operating margin reaching 38.7% evidence of significant operating leverage as its growth brands accelerate
BPC-157 (VEGF) (FGF)